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TL are important cytolytic effector cells of the immune defense system against viruses and tumors (1). CD4 + and CD8 + CTL are also involved in autoimmunity and transplant rejection. The recent development of mice in which the gene for perforin is disrupted (2-4) has provided evidence for the existence of two separate lytic pathways: first, the formation of membrane pores by perforin released from intracellular stores (5) followed by the proteolytic action of granzymes that are coreleased with perforin and that induce apoptosis in the target cell (6); second, the triggering of the Fas (Apo-1)-induced apoptotic pathway by Fas ligand (FasL) exposed on the CTL surface (7) . At present it appears that the two pathways account for all cytolytic activity of CTL. However, only a restricted number of target cells could be analyzed, since functional inactivation of the Fas pathway is achieved by the use of target cells from lpr mice, which express little or no Fas (8) . Thus, it cannot be excluded that other lytic molecules such as TNF-r which is detected on the surface of activated T lymphocytes (9) , contribute to the cytotoxicity of CTU For this reason we generated mice in which both perforin and FasL are nonfunctional, by crossing perforin knock-out mice with gld mice, which bear a mutation in the FasL gene leading to its functional inactivation (10) . Our study The first two authors contributed equally to this work. now shows that CTL derived from these mice still display lytic activity on transformed fibroblast cell lines.
These double-mutant mice also offered the unique possibility to evaluate the role ofperforin and FasL in GVHD. GVHD continues to be a major complication after allogeneic bone marrow transplantation (BMT) (11) . An acute lethal form of GVHD is caused by activation of the hostreactive donor effector T cells (12) . The major organs affected in GVHD are skin, liver, intestine, and lymphoid tissues (13, 14) , and symptoms range from varying degrees of erythroderma, wasting, diarrhea, splenomegaly, and lymphadenopathy to death (14) . The lytic mechanisms leading to lesion formation are only poorly understood and might involve, for acute GVHD, direct interactions between donor CTL and host target cells, or more indirect mechanisms mediated by interleukins released by the donor T cells (15) . We therefore explored the possibility that perforin or FasL may play a role in the etiology of the lesions seen in GVHD.
Materials and Methods
Animals. Pefforin-deficient (P-/-) gld/gld mice were generated by crossing pefforin knock-out (C57BL/6 • 129)F3 mice (16) with C57BL/6 gld/gld mice (The Jackson Laboratory, Bar Harbor, ME) and by subsequent intercrossing of heterozygous F1 animals. To detect the FasL-gld mutation, mouse tail DNA was PCR amplified using the following primers: 5'-CACTCAAG-GTCCATCCCTCTG-3' and 5'-ATATTCCTGGTGCCCAT-GAT-3'. The amplification product was sequenced to detect the gld homozygotes (17, 18) . Mice were screened for the defective perforin gene as described (16) .
Flow Cytometric Analysis. Splenocytes from 6-and 16-wk-old mice were isolated and freed from red blood cells by 15-min incubation in an ice cold buffer containing 13 mM sodium bicarbonate, 156 m/vl ammonium chloride, and 127 I~M EDTA, and then resuspended in PBS supplemented with 5% FCS and 0.02% NaN 3. Splenocytes were stained with Tri-Color-conjugated anti-B220 antibodies and HTC-labeled anti-CD3 antibodies (CAL-TAG Laboratories, South San Francisco, CA) and analyzed using a FACScan | flow cytometer (Becton Dickinson Immunocytometric Systems, Mountain View, CA) using the Lysis II software.
Cytolytic Assays. Alloreactive cytotoxic T lymphocytes were generated in a 5-d mixed lymphocyte culture (16) . Responder spleen cells (2.5 • 106/m1-1) were from adult 6-wk-old mice deficient for pefforin, functional FasL (gld/gld), or both. All mice were of H-2 b haplotype. Stimulators were irradiated spleen cells (2.5 • 106/ml -l, 3,000 rad) from either DBA/2 mice (H-2 d) or C3H (H-2 k) mice. Target ceils were activated splenocytes from DBA/2 mice stimulated with ConA (4 pLg/m1-1) for 3 d (2), A20.2J B cell lymphomas (H-2a), WEHI 164 fibrosarcomas (H-2a), and L929 (H-2 k) fibrosarcomas, all obtained from American Type Culture Collection (Rockviile, MD). Mouse embryonic fibroblasts (MEF) were isolated from 12 to 14-d-old C3H embryos as described (2) . Cytotoxicity on targets of hematopoietic origin was assayed after 4 h for SlCr release and DNA degradation (16) . Adherent target cells were labeled with SiCr for 12 h as described elsewhere (16), and SlCr release was determined after a 20-h incubation. Recombinant mouse TNF-ot was obtained from Dr. J. Browning, Biogen (Boston, MA).
Induction of G VHD. 6-wk-old female recipients were given a sublethal dose of Co irradiation (5 Gy; 1.2 Gy/min). Within 1 h, 40 • 106 of spleen cells isolated from female allogeneic donors were injected through the tail vein. Animals used in the study were BALB/c, C57BL/6, 129, (C57BL/6 • 129)F1, (C57BL/6 • 129)P -/-, C57BL/6 gld/gld, and (C57BL/6 X 129)p-l-girl~girl mice. R.ate of survival was recorded daily. Mice with the gld/gld mutation were used at 5-6 wk of age. A minimum of four recipient animals were used in each experimental group.
Results and Discussion
Mutant mice deficient for both perforin and functional FasL were generated by intercrossing P -/ -mice (16) with gld/gld mice (19) lacking functional FasL (17, 18) . Animals homozygous for both nonfunctional genes were viable. Flow immunocytometric analysis o f the spleen cell population of young animals (6 wk old) showed a phenotype similar to that observed in normal mice (Fig. 1 ). W i t h progressive age (from 8 wk old onward), however, these mice developed a more severe lymphadenopathy than the one previously described in gld/gld mice (19) . Lymphoid organs of P-/-gld/gld mice were massively enlarged. Spleens derived from 16-wk-old P-/-gld/gld mice were on average seven times heavier than those from age-matched P -/ -mice, or 3. .i2~;.," .. ~.~. tion accumulated (Fig. 1) that resembled the T cell population found in gld/gld mice (19) . This phenotype represented ~5 0 % of all splenocytes in 16-wk-old double-mutant mice (Fig. 1) . A high proportion of T cells in P-/-gld/gld mice expressed activation markers such as CD69 (data not shown), pointing to a chronic activation o f the immune system. Most mice died at an age o f 4-5 mo.
T cells from double mutant animals exhibited no lytic activity on several target cells tested. Whereas alloreactive T cells (H-2 b) derived from 6-wk-old P -/ -and gld/gld mice were able to kill ConA-stimulated allogeneic lymphoid cells (H-2 d) as well as the B cell lymphoma A20, splenocytes from P-/-gld/gld mice were completely inactive (Fig. 2) . The differences in cytotoxicity are unlikely to be caused by large differences in the allogeneic reaction, since IFN-~/ concentration in the supernatants of the respective mixed leukocyte reactions was similar (3,000 + 500 U / n i l supematant). These data thus confirm that perforin-and Fas-dependent pathways are responsible for all detectable lytic activity against lymphoid targets in short term cytotoxicity assays (2) (3) (4) 20) . Cytolytic activity was also tested in long-term (20 h) cytotoxicity assays against nonhematopoietic target cells, that is, the fibrosarcoma W E H I -1 6 4 (H-2a), L929 (H-2k), and MEF (H-2a). As shown in Fig. 3 of both perforin and functional FasL, but surprisingly, killing of WEHI-164 and L929 was not significantly affected. The sensitivity pattern of target cells correlated with their respective susceptibility to TNF-~t (Fig. 3 b) , a cytokine mainly secreted by activated macrophages, NK cells, and some subpopularions o f t cells (9) . TNF-tx has been shown in vitro to exhibit slow cytolytic activity (21) TNFc~ (ng/ml) [22] [23] [24] . This suggests that TNF-ot-mediated cytotoxicity is at least in part responsible for the lyric activity remaining in P-/-and FasL-deficient animals. Other cytolyric molecules, such as lymphotoxins (9) or NK lysins (25) , may also contribute to the residual cytotoxicity, since neutralizing anti-TNF-ot antibodies only partially inhibited this activity (10-30% specific reduction). GVHD remains the main complication after allogeneic BMT. Since the effector molecules leading to lesion formation are only poorly understood, we investigated the role of perforin-and Fas-mediated cytolytic pathways in a murine model of acute lethal GVHD whereby donor splenocytes from C57BL/6 or 129 (H-2 b) mice are injected into sublethally irradiated allogeneic BALB/c (H-2 a) mice (26) . Fig. 4 a shows that all BALB/c recipients injected with C57BL/6 or 129 spleen cells (40 X 106) died within 7 d, whereas injection of spleen cells from P-/-mice or functional FasL-deficient mice delayed the onset of the disease (survival mean 17 and 24 d, respectively). In contrast, mice given cells from P-/-gld/gld animals were unaffected and survived (survival mean >50 d). Whereas sublethally irradiated BALB/c mice die within 7 d when inoculated with normal C57BL/6 spleen cells (Fig. 4 a) , irradiated C57BL/6 (or 129) recipients injected with the same number of BALB/c spleen cells survive and show no signs of illness (Fig. 4 b) (26, 27) . Whether this difference of sensitivity reflects the ability of the C57BL/6 mice to eliminate potentially alloreactive BALB/c CTL from the graft or is caused by a low frequency of BALB/c anti-C57BL/6 CTL precursors in BALB/c splenocytes is not known. We therefore transferred normal BALB/c spleen cells into sublethally irradiated C57BL/6 recipients deficient for either perforin or functional FasL. BALB/c splenocytes failed to induce any symptoms of lethal GVHD in nomaal and gld/gld recipients (Fig. 4 b) . In contrast, C57BL/6 recipients lacking functional perforin became susceptible to BALB/c splenocytes and died within 7-8 d. Thus, normal sublethally irradiated C57BL/6 recipients contain radioresistant cells that are able to suppress the effector function of BALB/c splenocytes solely through a pefforin-dependent pathway. The cell population responsible for this inhibition might include host antidonor radioresistant CTL, NK cells, or natural suppressor cells appearing after total body irradiation (27, 28) .
In the murine model of lethal GVHD studied here, both perforin and FasL appear to play a crucial role in mortality. Other lytic effector molecules still detected in perforinFasL-deficient lymphocytes contribute little, although our study cannot exclude the involvement of TNF-0~ or other cytokines in milder forms of GVHD, as suggested by others (15, 23) . In vivo, pefforin's implication in the clearance of lymphocytic cboriomeningitis virus infection and fibrosarcoma tumor cells is well established (4, 29) , whereas the Fas system was shown to be involved in the elimination of activated lymphocytes in the periphery (7, 30) . This study now demonstrates that FasL also participates in pathological tissue damage during GVHD, in agreement with the observation that injection of anti-Fas antibodies into adult mice can cause rapid death due to liver failure (31) . In view of the massive upregulation of FasL in functional Fas receptor-lacking Ipr (lymphoproliferation) mice (32, 33) , the severe wasting syndrome (GVHD) observed when lpr bone marrow-derived cells are adoptively transferred into a syngeneic wild-type recipient (34) may also be explained. Tissues attacked in FasL-mediated GVHD probably include those that abundantly express Fas, such as liver, lung, or heart, whereas pefforin, with no requirement for a specific receptor (35) , may eventually destroy any organ.
Although both perforin-and Fas-dependent pathways are responsible for the mortality caused by acute GVHD in BALB/c mice, perforin-mediated cytotoxicity appears to be the only pathway required for the rejection ofallogeneic spleen cells. P-/-mice still reject heart allografts (36), and thus effector mechanisms used to reject tissues and organs of different origin seem to differ.
GVHD remains a major barrier to a wider application of allogeneic BMT for a variety of diseases. Provided that the active role of FasL and pefforin in the progression of acute GVHD can be illustrated in humans, the development of therapeutic strategies aimed at controlling the two cytolytic pathways during BMT may be an approach for decreasing the risk of GVHD.
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